IndraLab

Statements

Olmesartan inhibits MAPK14. 1 / 1

| 1

➶

reach

"Olmesartan based treatment decreased both high CSBP and morning HSBP in the PCH group to the same degree."

24766515

INDRA sources:

Colored badges next to statement headings correspond to evidence counts from knowledge sources, as shown below. Badges to the left of the | separator correspond to curated knowledge base sources, and badges to the right of it correspond to machine reading systems.

IndraLab

Statements

Olmesartan inhibits MAPK14. 1 / 1

INDRA sources:

Databases

Reading